AAAAAA

   
Results: 1-18 |
Results: 18
RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS
Authors: KEILHOLZ U CONRADT C LEGHA SS KHAYAT D SCHEIBENBOGEN C THATCHER N GOEY SH GORE M DORVAL T HANCOCK B PUNT CJA DUMMER R AVRIL MF BROCKER EB BENHAMMOUDA A EGGERMONT AMM PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929
HIGH-DOSE REGIMEN OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN COMBINATION WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC RENAL-CELL-CANCER
Authors: KRUIT WHJ GOEY SH LAMERS CHJ GRATAMA JW VISSER B SCHMITZ PIM EGGERMONT AMM BOLHUIS RLH STOTER G
Citation: Whj. Kruit et al., HIGH-DOSE REGIMEN OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN COMBINATION WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC RENAL-CELL-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 312-320
A RANDOMIZED TRIAL OF IFN-ALPHA IL-2 WITH OR WITHOUT CDDP IN ADVANCEDMELANOMA - AN EORTC MELANOMA COOPERATIVE GROUP TRIAL/
Authors: KEILHOLZ U GOEY SH PUNT CJA SCHEIBENBOGEN C PROEBSTLE T SALZMANN R SCHADENDORF D LIENARD D EGGERMONT AMM
Citation: U. Keilholz et al., A RANDOMIZED TRIAL OF IFN-ALPHA IL-2 WITH OR WITHOUT CDDP IN ADVANCEDMELANOMA - AN EORTC MELANOMA COOPERATIVE GROUP TRIAL/, European journal of cancer, 33, 1997, pp. 1159-1159
INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP
Authors: KEILHOLZ U GOEY SH PUNT CJA PROEBSTLE TM SALZMANN R SCHEIBENBOGEN C SCHADENDORF D LIENARD D ENK A DUMMER R HANTICH B GEUEKE AM EGGERMONT AMM
Citation: U. Keilholz et al., INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP, Journal of clinical oncology, 15(7), 1997, pp. 2579-2588
TUNNELED CENTRAL VENOUS CATHETERS YIELD A LAW INCIDENCE OF SEPTICEMIAIN INTERLEUKIN-2-TREATED PATIENTS
Authors: GOEY SH VERWEIJ J BOLHUIS RLH DEGOOYER D EGGERMONT AMM SCHMITZ PIM STOTER G
Citation: Sh. Goey et al., TUNNELED CENTRAL VENOUS CATHETERS YIELD A LAW INCIDENCE OF SEPTICEMIAIN INTERLEUKIN-2-TREATED PATIENTS, Cancer immunology and immunotherapy, 44(5), 1997, pp. 301-304
PHASE-II STUDY OF A SHORT-COURSE OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH LONG-TERM ORAL ETOPOSIDE IN METASTATIC MALIGNANT-MELANOMA
Authors: PLANTING AST VANDERBURG MEL GOEY SH SCHELLENS JHM VECHT C DEBOERDENNERT M STOTER G VERWEIJ J
Citation: Ast. Planting et al., PHASE-II STUDY OF A SHORT-COURSE OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH LONG-TERM ORAL ETOPOSIDE IN METASTATIC MALIGNANT-MELANOMA, European journal of cancer, 32A(11), 1996, pp. 2026-2028
IMMUNOTHERAPY OF METASTATIC RENAL-CELL CANCER
Authors: GOEY SH VERWEIJ J STOTER G
Citation: Sh. Goey et al., IMMUNOTHERAPY OF METASTATIC RENAL-CELL CANCER, Annals of oncology, 7(9), 1996, pp. 887-900
PROLONGED CONTINUOUS HEPATIC-ARTERY INFUSION WITH INTERLEUKIN-2 IN UNRESECTABLE LIVER METASTASES OF COLORECTAL-CANCER - A PHASE IA-B STUDY
Authors: GOEY SH EGGERMONT AMM OSKAM R WIGGERS T BOLHUIS RLH STOTER G
Citation: Sh. Goey et al., PROLONGED CONTINUOUS HEPATIC-ARTERY INFUSION WITH INTERLEUKIN-2 IN UNRESECTABLE LIVER METASTASES OF COLORECTAL-CANCER - A PHASE IA-B STUDY, Annals of oncology, 7(3), 1996, pp. 317-319
MODULATION OF IMMUNE PARAMETERS IN PATIENTS WITH METASTATIC RENAL-CELL CANCER RECEIVING COMBINATION IMMUNOTHERAPY (IL-2, IFN-ALPHA AND AUTOLOGOUS IL-2-ACTIVATED LYMPHOCYTES)
Authors: GRATAMA JW SCHMITZ PIM GOEY SH LAMERS CHJ STOTER G BOLHUIS RLH
Citation: Jw. Gratama et al., MODULATION OF IMMUNE PARAMETERS IN PATIENTS WITH METASTATIC RENAL-CELL CANCER RECEIVING COMBINATION IMMUNOTHERAPY (IL-2, IFN-ALPHA AND AUTOLOGOUS IL-2-ACTIVATED LYMPHOCYTES), International journal of cancer, 65(2), 1996, pp. 152-160
DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA
Authors: KRUIT WHJ PUNT CJA GOEY SH DEMULDER PHM GRATAMA JW EGGERMONT AMM BOLHUIS RLH STOTER G
Citation: Whj. Kruit et al., DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA, British Journal of Cancer, 74(6), 1996, pp. 951-955
INTERLEUKIN-2 AND INTERFERON ALPHA-2A DO NOT IMPROVE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER
Authors: GOEY SH GRATAMA JW PRIMROSE JN WARD U MERTELSMANN RH OSTERWALDER B VERWEIJ J STOTER G
Citation: Sh. Goey et al., INTERLEUKIN-2 AND INTERFERON ALPHA-2A DO NOT IMPROVE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER, British Journal of Cancer, 74(12), 1996, pp. 2018-2023
REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY
Authors: CANEVARI S STOTER G ARIENTI F BOLIS G COLNAGHI MI DIRE EM EGGERMONT AMM GOEY SH GRATAMA JW LAMERS CHJ NOOY MA PARMIANI G RASPAGLIESI F RAVAGNANI F SCARFONE G TRIMBOS JB WARNAAR SO BOLHUIS RLH
Citation: S. Canevari et al., REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY, Journal of the National Cancer Institute, 87(19), 1995, pp. 1463-1469
PHASE-II STUDY OF A SHORT-COURSE OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH LONG-TERM ORAL ETOPOSIDE IN PLEURAL MESOTHELIOMA
Authors: PLANTING AST VANDERBURG MEL GOEY SH SCHELLENS JHM VANDENBENT MJ DEBOERDENNERT M STOTER G VERWEIJ J
Citation: Ast. Planting et al., PHASE-II STUDY OF A SHORT-COURSE OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH LONG-TERM ORAL ETOPOSIDE IN PLEURAL MESOTHELIOMA, Annals of oncology, 6(6), 1995, pp. 613-615
INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 IN PLEURAL MESOTHELIOMA - A PHASE I-II STUDY
Authors: GOEY SH EGGERMONT AMM PUNT CJA SLINGERLAND R GRATAMA JW OOSTEROM R OSKAM R BOLHUIS RLH STOTER G
Citation: Sh. Goey et al., INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 IN PLEURAL MESOTHELIOMA - A PHASE I-II STUDY, British Journal of Cancer, 72(5), 1995, pp. 1283-1288
FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA
Authors: KRUIT WHJ GOEY SH CALABRESI F LINDEMANN A STAHEL RA POLIWODA H OSTERWALDER B STOTER G
Citation: Whj. Kruit et al., FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA, British Journal of Cancer, 71(6), 1995, pp. 1319-1321
WEEKLY HIGH-DOSE CISPLATIN IN MALIGNANT PLEURAL MESOTHELIOMA
Authors: PLANTING AST SCHELLENS JHM GOEY SH VANDERBURG MEL DEBOERDENNERT M STOTER G VERWEIJ J
Citation: Ast. Planting et al., WEEKLY HIGH-DOSE CISPLATIN IN MALIGNANT PLEURAL MESOTHELIOMA, Annals of oncology, 5(4), 1994, pp. 373-374
CARDIOTOXICITY AS A DOSE-LIMITING FACTOR IN A SCHEDULE OF HIGH-DOSE BOLUS THERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON - AN UNEXPECTEDLYFREQUENT COMPLICATION
Authors: KRUIT WH PUNT KJ GOEY SH DEMULDER PH VANHOOGENHUYZE DC HENZENLOGMANS SC STOTER G
Citation: Wh. Kruit et al., CARDIOTOXICITY AS A DOSE-LIMITING FACTOR IN A SCHEDULE OF HIGH-DOSE BOLUS THERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON - AN UNEXPECTEDLYFREQUENT COMPLICATION, Cancer, 74(10), 1994, pp. 2850-2856
INTERLEUKIN-2-INDUCED THYROID-DYSFUNCTION IS CORRELATED WITH TREATMENT DURATION BUT NOT WITH TUMOR RESPONSE
Authors: KRUIT WHJ BOLHUIS RLH GOEY SH JANSEN RLH EGGERMONT AMM BATCHELOR D SCHMITZ PIM STOTER G
Citation: Whj. Kruit et al., INTERLEUKIN-2-INDUCED THYROID-DYSFUNCTION IS CORRELATED WITH TREATMENT DURATION BUT NOT WITH TUMOR RESPONSE, Journal of clinical oncology, 11(5), 1993, pp. 921-924
Risultati: 1-18 |